Catalyst Wire Dossier Catalyst Wire Dossier

Amlodipine Besylate and Olmesartan Medoxomil

amlodipine besylate and olmesartan medoxomil · Ajanta Pharma USA Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Amlodipine Besylate and Olmesartan Medoxomil, covering 2016-10-28 to 2023-06-23. Get the full timeline:

Most recent: FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)

See pricing